With declining renal mass, patients with CKD lose the ability to produce erythropoietin (EPO) and develop anemia due to low blood iron, inflammation, hemorrhage, EPO resistance, or relative EPO deficiency. This evidence concerns the gene EPO and chronic kidney disease.